Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. G-csf, N-met-ala(1)-thr(3)-tyr(4)-arg(5)-ser(17)-
2. G-csf, N-methionyl-alanyl(1)-threonyl(3)-tyrosyl(4)-arginyl(5)-seryl(17)-
3. Granulocyte-colony-stimulating Factor, N-met-ala(1)-thr(3)-tyr(4)-arg(5)-ser(17)-
4. Kw 2228
5. Kw-2228
6. N-l-methionyl-1-l-alanine-3-l-threonine-4-l-tyrosine-5-l-arginine-17-l-serine-csf
| Molecular Weight | 727.8 g/mol |
|---|---|
| Molecular Formula | C30H49N9O10S |
| XLogP3 | -5.3 |
| Hydrogen Bond Donor Count | 12 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 22 |
| Exact Mass | 727.33230997 g/mol |
| Monoisotopic Mass | 727.33230997 g/mol |
| Topological Polar Surface Area | 359 Ų |
| Heavy Atom Count | 50 |
| Formal Charge | 0 |
| Complexity | 1170 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
39
PharmaCompass offers a list of Nartograstim API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nartograstim manufacturer or Nartograstim supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nartograstim manufacturer or Nartograstim supplier.
PharmaCompass also assists you with knowing the Nartograstim API Price utilized in the formulation of products. Nartograstim API Price is not always fixed or binding as the Nartograstim Price is obtained through a variety of data sources. The Nartograstim Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Nartograstim manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nartograstim, including repackagers and relabelers. The FDA regulates Nartograstim manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nartograstim API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Nartograstim supplier is an individual or a company that provides Nartograstim active pharmaceutical ingredient (API) or Nartograstim finished formulations upon request. The Nartograstim suppliers may include Nartograstim API manufacturers, exporters, distributors and traders.
Nartograstim Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nartograstim GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nartograstim GMP manufacturer or Nartograstim GMP API supplier for your needs.
A Nartograstim CoA (Certificate of Analysis) is a formal document that attests to Nartograstim's compliance with Nartograstim specifications and serves as a tool for batch-level quality control.
Nartograstim CoA mostly includes findings from lab analyses of a specific batch. For each Nartograstim CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nartograstim may be tested according to a variety of international standards, such as European Pharmacopoeia (Nartograstim EP), Nartograstim JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nartograstim USP).
